Antibody Engineering & Therapeutics taking place December 11-15, 2017 in San Diego, CA is the largest meeting bringing you the latest science, technologies and partners needed to accelerate next generation antibodies towards commercial success.
Here’s What You Will Get at Antibody Engineering & Therapeutics 2017:
900+ANTIBODY SCIENTISTS AND EXECUTIVES
Collaborate with leading pharma, biotech, academia and solution providers from North America, Asia and Europe to fast-track your antibody research to the clinic and beyond.
125+ GLOBAL SPEAKER PRESENTATIONS
Expand your pipeline of antibody therapeutics by hearing case studies, new data and industry updates from experts working across the entire spectrum of antibody development and production.
Accelerate your promising therapeutic towards commercial success by connecting with leading technology and service providers.
100+ PEER-SUBMITTED POSTERS
Stay at the forefront of antibody innovation by accessing cutting-edge and unpublished data from fellow attendees.
NEW THIS YEAR!
- Session on Overcoming Delivery Challenges Including Brain & Intracellular Targets
- Full-Day Track on Antibody-Based Innovations in the Tumor Microenvironment
- Workshop on Screening Against Cell-Surface Targets
- More Examples of Novel Therapeutic Indications and Non-Cancer Antibodies
Expanded Focus on Immunotherapy, Immuno-oncology and Immune Mechanisms
Distinguished Keynote Presenters Will Share Strategies to Accelerate Your Antibody Molecules including:
| James Crowe, MD
Deciphering the Human Immunome
| Andreas Plückthun, Ph.D.
University of Zurich
| William Pardridge,
Biologic Drug Delivery
Across the Blood-Brain
Barrier with IgG Fusion
| Peter Chin, MD
Ocrelizumab in Relapsing and Primary Progressive Multiple Sclerosis
REGISTER BY AUGUST 18TH AND SAVE UP TO $400
CAS members will enjoy 10% off on registration fee with the promotion code: CASSociety